Axxess Pharma Inc (OTCMKTS:AXXE) gets FDA Approval for selling a number of vital medicines

Specialty pharmaceutical and nutritional supplements firm, Axxess Pharma Inc(OTCMKTS:AXXE)’s subsidiary, AllStar Health Brands, has got FDA approval from the United States for selling extremely powerful Omega-3 fish oil, Muscle Recovery supplements, Muscle Growth and Turbo Blend Protein Powders.

This approval comes very soon after the firm’s successful meetings with two of USA’s largest distributors. The firm’s FDA approval would not allow distribution of products nationally to big box retail chain stores but also make it easier to enter regulated markets like Mexico and other foreign jurisdictions.

The company is hoping that this would expedite the rate of present sales overseas. Management is projecting year over year sales until next year fiscal of $2.5 million.

President of Axxess Pharma, Dr. Daniel Bagi, stated that the company is glad to get FDA approval for selling latest products of all-natural TapouT supplements.

He added that the unique high potency Omega-3 fish oil supplements may be one of the top sellers both in the US and internationally.

Senior Consultant of Medical Affairs for Axxess Pharma, Dr. Fred Maese, opined that over 100 million Americans are in danger for hypertension, cardiovascular disease, stroke, obesity, diabetes, mood disorders, and premature aging.

He adds that it is strongly recommended for a healthy lifestyle and two daily soft-gel caps of the TapouT Premium Omega-3 Fish Oil would lead to optimal quality of life!

Dr. Maese further stated that since he is a cardiologist he endorses the top quality nutraceutical, especially in those with high blood pressure and hardening of the arteries.

Axxess Pharma is a Nevada Corporation which operates through its wholly owned Canadian Subsidiary: Axxess Pharma Canada.

The company aims to improve health and quality of life through select medicines as well as nutritional supplements all over Americas.


Related News

Leave a Reply

Your email address will not be published. Required fields are marked *

Copyrıght 2015 All RIGHTS RESERVED.